公开(公告)号：US20070197456A1

公开(公告)日：2007-08-23

申请号：US11508897

申请日：2006-08-24

申请人： Peter Jenkins ,  Minnie Wu ,  David Wu

发明人： Peter Jenkins ,  Minnie Wu ,  David Wu

IPC分类号： A61K31/704 ,  A61K31/22 ,  A61K31/19 ,  C12P19/62 ,  C12P7/40

CPC分类号： A61K31/22 ,  A61K31/19 ,  A61K31/704

摘要： The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions.

摘要翻译： 本发明涉及式（1）化合物（赤霉素）及其衍生物在制备用于治疗糖尿病及其并发症及相关病症的药物组合物或药物中的应用，包括肥胖症，微血管病变和大血管病，肾病 ，神经病，眼病，糖尿病性溃疡等。 该方法使血清葡萄糖水平和其他生理条件正常化。

公开(公告)号：US20050215496A1

公开(公告)日：2005-09-29

申请号：US11133207

申请日：2005-05-20

申请人： Peter Jenkins ,  Minnie Wu ,  David Wu

发明人： Peter Jenkins ,  Minnie Wu ,  David Wu

IPC分类号： C07D307/00 ,  A61K31/19 ,  A61K31/343 ,  A61K35/74 ,  A61K45/00 ,  A61P1/04 ,  A61P3/04 ,  A61P3/10 ,  A61P9/00 ,  A61P27/02 ,  A61K31/704 ,  A61K31/20

CPC分类号： A61K31/22 ,  A61K31/19 ,  A61K31/704

摘要： The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions.

摘要翻译： 本发明涉及式（1）化合物（赤霉素）及其衍生物在制备用于治疗糖尿病及其并发症及相关病症的药物组合物或药物中的应用，包括肥胖症，微血管病变和大血管病，肾病 ，神经病，眼病，糖尿病性溃疡等。 该方法使血清葡萄糖水平和其他生理条件正常化。

公开(公告)号：US07435756B2

公开(公告)日：2008-10-14

申请号：US10776188

申请日：2004-02-12

申请人： Peter James Jenkins ,  Minnie Wu ,  David Shine Wu

发明人： Peter James Jenkins ,  Minnie Wu ,  David Shine Wu

IPC分类号： A61K31/21

CPC分类号： A61K31/22 ,  A61K31/19 ,  A61K31/704

摘要： The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions

摘要翻译： 本发明涉及式（1）化合物（赤霉素）及其衍生物在制备用于治疗糖尿病及其并发症及相关病症的药物组合物或药物中的应用，包括肥胖症，微血管病变和大血管病，肾病 ，神经病，眼病，糖尿病性溃疡等。 该方法使血清葡萄糖水平和其他生理条件正常化

公开(公告)号：US07968596B2

公开(公告)日：2011-06-28

申请号：US11508897

申请日：2006-08-24

申请人： Peter James Jenkins ,  Minnie Wu ,  David Shine Wu

发明人： Peter James Jenkins ,  Minnie Wu ,  David Shine Wu

IPC分类号： A61K31/21

CPC分类号： A61K31/22 ,  A61K31/19 ,  A61K31/704

摘要： The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions.

摘要翻译： 本发明涉及式（1）化合物（赤霉素）及其衍生物在制备用于治疗糖尿病及其并发症及相关病症的药物组合物或药物中的应用，包括肥胖症，微血管病变和大血管病，肾病 ，神经病，眼病，糖尿病性溃疡等。 该方法使血清葡萄糖水平和其他生理条件正常化。